Clinical Trial Update: Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating expanded multi-antigen specific lymphocytes for solid tumors. The trial is actively not recruiting and sponsored by Child…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Expanded multi-antigen specific lymphocytes

Snippet

Sponsor: Children's National Research Institute | Conditions: Solid Tumors | Phase 1 | Status: ACTIVE_NOT_RECRUITING